Premium
Murrayanine Attenuates Lipopolysaccharide‐induced Inflammation and Protects Mice from Sepsis‐associated Organ Failure
Author(s) -
Gupta Shilpa,
Khajuria Vidushi,
wani Abubakar,
Nalli Yedukondalu,
Bhagat Asha,
Ali Asif,
Ahmed Zabeer
Publication year - 2019
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/bcpt.13032
Subject(s) - lipopolysaccharide , in vivo , sepsis , pharmacology , inflammation , tumor necrosis factor alpha , medicine , immunology , chemistry , biology , microbiology and biotechnology
Murrayanine ( MK ) is the main compound isolated from Murraya koenigii, an aromatic plant belonging to the Rutaceae family, also known as curry leaf tree. Murrayanine was reported to possess potential antioxidant, antimycobacterial and antifungal effects. However, its effect in sepsis remains unclear. This study was designed to investigate the anti‐inflammatory effect of MK using both in vitro and in vivo assay. Results of this study indicated that MK decreased NO , TNF ‐α and IL ‐6 production in both lipopolysaccharide ( LPS )‐stimulated RAW 264.7 cells and murine peritoneal macrophages. Moreover, iNOS and COX ‐2 protein expression as well as their downstream product, PGE 2, was also decreased effectively in RAW 264.7 cells. Furthermore, MK decreased the phosphorylation of IKB and repressed NF ‐ kB activity in LPS ‐activated RAW 264.7 cells. Additionally, we evaluated MK efficacy in vivo using LPS ‐induced sepsis, a systemic inflammation model in mice. Administration of MK inhibits pro‐inflammatory cytokines ( TNF ‐α and IL ‐6) secretion; decreases AST , ALT , BUN and CRE level in mouse sera; mitigates lung, liver and kidney injuries; and also increases LPS ‐challenged mice survival rate. Collectively, our results suggest that MK exerts potential as a new anti‐inflammatory and immunosuppressive drug in sepsis treatment.